close

Street Signs: A bitter pill for Gland Pharma, Small-cap stock's F&O & more

Capital markets regulator Securities and Exchange Board of India plans to ease a rule that will make fund managers breathe a little easier

Abhishek KumarSamie Modak
markets
Premium

Listen to This Article

Fund managers may get their smartphones back
Capital markets regulator Securities and Exchange Board of India plans to ease a rule that will make fund managers breathe a little easier. In a consultation paper, Sebi said it may allow asset management companies (AMCs) to relax the present practice of recording all communications by fund managers and barring access to personal mobile phones during market hours. The lack of access to phones has been a major pain point for fund managers, given that their usage goes beyond calling — from making financial transactions to conducting numerous day-to-day affairs. Many AMCs may refuse to relax the provision to stay on the safe side.
A bitter pill for Gland Pharma: Locked at 20% lower circuit
Or

Also Read

Fosun's sale of Gland Pharma to become India's biggest pharma deal: Report

Gland Pharma to acquire French firm Cenexi Group for Rs 1,000 crore

Gland Pharma stock seen underperforming after acquiring France's Cenexi

AU Small Finance tumbles 5% in 4 sessions; what should investors do?

Active mid-cap, small-cap schemes fly high with 'benchmark-beating' returns

First Published: May 22 2023 | 6:10 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to read more on Business-Standard.com